Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Pascagoula, MS MSA — September 2026
Pascagoula's tight labor market masks a scientific talent shortage.
Jackson County unemployment sits at 3.5% and manufacturing pays $82,884 on average, but metro CRA advertised pay of $73,374 still trails the $90,956 national median, exposing a credentialed-talent gap outsourcing can't fully solve.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Jackson County unemployment: 3.5% — July 2026, below MS statewide 3.7%
- CRA advertised pay, metro vs national: $73,374 vs $90,956 — Metro trails national median by ~19%
- MS job openings rate: 5.4% — vs 4.5% national rate, Oct 2025
- Manufacturing wage premium, Jackson County: $82,884 — vs $58,319 county average annual wage
Key takeaways
CRA pay lags the national market by nearly $17,600.
Metro median advertised pay of $73,374 trails the $90,956 national figure even as both trend upward, indicating local employers may be pricing against a thinner regional labor market rather than national competition for this credential. Sponsors relying on Gulf Coast site staff should stress-test whether that gap is costing them qualified applicants.
Manufacturing's gravity pulls talent away from life sciences roles.
Manufacturing wages average $82,884 annually in Jackson County, well above the county's $58,319 overall average, giving life sciences employers direct wage competition from shipbuilding and industrial employers for technically skilled workers. This raises the bar for what quality and lab-adjacent roles must offer to compete locally.
State-level talent decline makes outsourcing look structural, not tactical.
Mississippi's projected 0.1% annual employment decline through 2030, paired with falling generic pharma manufacturing employment, suggests CDMO and CRO partnerships are becoming the default rather than a stopgap for Gulf Coast-based life sciences operations. Leaders planning multi-year manufacturing or clinical footprints should weight outsourcing economics accordingly.
Low metro unemployment doesn't mean deep bench strength.
Jackson County's 3.5% unemployment rate reflects full industrial employment, not availability of regulatory, clinical, or CMC-trained candidates — a distinction that matters when forecasting time-to-fill for specialized roles. Recruitment timelines built on general labor market tightness will likely understate the real search duration for credentialed scientific talent.
Median advertised pay by role — Pascagoula, MS MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $109,700 | $115,594 | $117,067 | Significant increase | $131,354 |
| Clinical Research Associate * | $50,835 | $73,374 | $99,605 | Significant increase | $90,956 |
| Lab Technician * | $39,520 | $40,492 | $46,279 | Moderate decline | $47,402 |
| Regulatory Affairs Specialist * | $78,759 | $111,675 | $111,675 | Significant increase | $104,000 |
| Clinical Data Manager | — | — | — | No data | $123,031 |
| Biostatistician * | $98,529 | $135,548 | $144,199 | No data | $133,322 |
| Validation Engineer * | $105,020 | $105,020 | $105,020 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Jackson County's 3.5% unemployment rate and manufacturing-dominated economy — 52.4% of GDP versus 14.8% statewide, anchored by Ingalls Shipbuilding and Chevron — leave little slack in a labor pool life sciences employers would need for clinical, quality, or regulatory hires. Mississippi's statewide job openings rate of 5.4% in October 2025, well above the 4.5% national rate, combined with projected flat-to-declining state employment growth through 2030, signals a metro where specialized scientific talent is structurally scarce rather than cyclically tight.
What it means
Clinical Research Associate advertised pay in this metro sits at a $73,374 median against a $90,956 national figure — a gap that may suggest local employers are either underpricing a scarce credential or drawing from a thinner, less credentialed applicant pool, both of which complicate CRO-site staffing and headcount planning for any sponsor running trials in the Gulf Coast corridor. Mississippi's declining generic pharmaceutical manufacturing employment and absence of a deep regulatory or CMC talent base reinforce that build-vs-outsource decisions in this metro tilt toward CDMO and CRO partnerships rather than internal capacity expansion. Organizations should evaluate whether local CRA and clinical-ops pay needs to move toward national benchmarks to compete for the thin pool of credentialed candidates, or whether remote/hybrid sourcing outside the MSA better solves the gap.
Looking ahead
Worth watching: Mississippi's 12 WARN notices in 2026 are concentrated in manufacturing and healthcare, not life sciences, but any Jackson County-specific filing from Ingalls or Chevron could shift local wage competition for technical talent. Watch whether released industrial workers show interest in adjacent quality or EHS roles.
Emerging pressure point: National CRA advertised pay is rising faster than the metro figure, a gap that could widen further if sponsors running multi-site trials begin offering remote or hybrid CRA arrangements that bypass the local labor pool entirely. Compensation teams should track whether Gulf Coast site postings start reflecting national rather than regional pay bands.
Potential inflection point: Hitachi Energy's state-level investment announcement signals continued industrial capital inflow to Mississippi, which may further tighten competition for technical and engineering talent that life sciences manufacturing and quality functions also draw from. Monitor whether this pulls CMC or process engineering candidates further toward industrial employers.
Early indicator: National biopharma hiring remains selective despite September layoffs at BioMarin and Bristol Myers, with 64% of organizations still actively recruiting — a pattern that, if it reaches Gulf Coast-based CRO and CDMO operations, would tighten competition for the region's limited regulatory and quality talent pool further.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.